Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression of the readthrough transcript CiDRE in alveolar macrophages boosts SARS-CoV-2 susceptibility and promotes COVID-19 severity.
Mitsui Y, Suzuki T, Kuniyoshi K, Inamo J, Yamaguchi K, Komuro M, Watanabe J, Edamoto M, Li S, Kouno T, Oba S, Hosoya T, Masuhiro K, Naito Y, Koyama S, Sakaguchi N, Standley DM, Shin JW, Akira S, Yasuda S, Miyazaki Y, Kochi Y, Kumanogoh A, Okamoto T, Satoh T. Mitsui Y, et al. Among authors: masuhiro k. Immunity. 2023 Aug 8;56(8):1939-1954.e12. doi: 10.1016/j.immuni.2023.06.013. Epub 2023 Jul 12. Immunity. 2023. PMID: 37442134
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study.
Shiroyama T, Nagatomo I, Koyama S, Hirata H, Nishida S, Miyake K, Fukushima K, Shirai Y, Mitsui Y, Takata S, Masuhiro K, Yaga M, Iwahori K, Takeda Y, Kida H, Kumanogoh A. Shiroyama T, et al. Among authors: masuhiro k. Sci Rep. 2019 Feb 21;9(1):2447. doi: 10.1038/s41598-019-39120-6. Sci Rep. 2019. PMID: 30792455 Free PMC article.
Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancer.
Masuhiro K, Tamiya M, Fujimoto K, Koyama S, Naito Y, Osa A, Hirai T, Suzuki H, Okamoto N, Shiroyama T, Nishino K, Adachi Y, Nii T, Kinugasa-Katayama Y, Kajihara A, Morita T, Imoto S, Uematsu S, Irie T, Okuzaki D, Aoshi T, Takeda Y, Kumagai T, Hirashima T, Kumanogoh A. Masuhiro K, et al. JCI Insight. 2022 May 9;7(9):e157915. doi: 10.1172/jci.insight.157915. JCI Insight. 2022. PMID: 35389889 Free PMC article.
Leucine-rich a-2 glycoprotein as a potential biomarker of idiopathic multicentric Castleman disease with pulmonary involvement: a single-center case-control study from Japan.
Takata S, Takeda Y, Hirata H, Shirai Y, Morita T, Futami Y, Naito Y, Masuhiro K, Shiroyama T, Miyake K, Naka T, Kumanogoh A. Takata S, et al. Among authors: masuhiro k. J Thorac Dis. 2022 May;14(5):1332-1341. doi: 10.21037/jtd-21-1973. J Thorac Dis. 2022. PMID: 35693615 Free PMC article.
Identifying phenotypes in interstitial lung disease using group-based trajectory modelling.
Takata S, Komukai S, Hoshino T, Tabuchi H, Masuhiro K, Yaga M, Shirai Y, Mitsui Y, Abe Y, Kuge T, Fukushima K, Kida H, Kumanogoh A. Takata S, et al. Among authors: masuhiro k. Int J Tuberc Lung Dis. 2023 Apr 1;27(4):332-334. doi: 10.5588/ijtld.22.0417. Int J Tuberc Lung Dis. 2023. PMID: 37035968 Free PMC article. No abstract available.
35 results